Compare ACIC & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACIC | AUTL |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.2M | 433.8M |
| IPO Year | N/A | 2018 |
| Metric | ACIC | AUTL |
|---|---|---|
| Price | $11.09 | $1.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | N/A | ★ $8.33 |
| AVG Volume (30 Days) | 154.0K | ★ 2.7M |
| Earning Date | 02-26-2026 | 11-12-2025 |
| Dividend Yield | ★ 6.67% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.71 | N/A |
| Revenue | ★ $328,331,000.00 | $51,128,000.00 |
| Revenue This Year | $5.03 | $672.42 |
| Revenue Next Year | $2.40 | $84.48 |
| P/E Ratio | $6.49 | ★ N/A |
| Revenue Growth | 22.22 | ★ 406.67 |
| 52 Week Low | $9.97 | $1.11 |
| 52 Week High | $13.50 | $2.70 |
| Indicator | ACIC | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 36.27 | 37.52 |
| Support Level | $10.90 | $1.34 |
| Resistance Level | $11.45 | $1.97 |
| Average True Range (ATR) | 0.32 | 0.15 |
| MACD | -0.10 | -0.07 |
| Stochastic Oscillator | 9.92 | 5.48 |
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.